A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

Arthritis and Rheumatism
Walter MaksymowychAnthony S Russell

Abstract

To determine the safety and efficacy of intravenous (IV) pamidronate treatment in ankylosing spondylitis (AS) patients who have had a suboptimal response to nonsteroidal antiinflammatory drugs (NSAIDs). Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug. The drug were given monthly for 6 months in a randomized double-blind, controlled trial. The inclusion criterion was active disease (Bath AS Disease Activity Index [BASDAI] of > or = 4 or morning stiffness of > or = 45 minutes) despite stable NSAID therapy. The primary outcome measure was the BASDAI, and secondary outcomes included the Bath AS Functional Index (BASFI), Bath AS Global Index (BASGI), Bath AS Metrology Index (BASMI), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, and percentage of patients achieving a reduction of > or = 25% in the BASDAI. Outcome assessments were done at -2, 0, 12, and 24 weeks, and analysis was by intent to treat. Eighty-four AS patients (67 men and 17 women; mean age 39.6 years and mean disease duration 15.1 years) were enrolled. Dosage groups were well matched at baseline for demographics, disease activi...Continue Reading

References

Feb 1, 1975·Annals of the Rheumatic Diseases·E G Pasion, J W Goodfellow
Oct 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M G Cecchini, H Fleisch
Jan 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M Sato, W Grasser
Dec 1, 1990·Arthritis and Rheumatism·H AhlströmR Hällgren
Apr 1, 1986·Calcified Tissue International·P H Stevenson, J R Stevenson
Dec 1, 1987·Calcified Tissue International·S AdamiV Lo Cascio
Jan 1, 1986·Annals of the Rheumatic Diseases·A BarbierR Roncucci
Jun 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D H SchweitzerS E Papapoulos
Nov 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P SansoniE G Engleman
Jan 1, 1996·British Journal of Rheumatology·S D JonesA Calin
Apr 29, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S P LuckmanM J Rogers
Oct 6, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R G RussellH A Fleisch
Oct 20, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R G RussellM J Rogers
Oct 21, 1999·Biochemical and Biophysical Research Communications·E van BeekS Papapoulos
Oct 3, 2000·Arthritis and Rheumatism·R J FrançoisE G Bywaters
Apr 3, 2001·Annals of Internal Medicine·D T FelsonD R Gale

❮ Previous
Next ❯

Citations

Aug 10, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T ArmingeatP Lafforgue
Jun 27, 2006·Rheumatology International·Melissa PadovanFrancesco Trotta
Jun 30, 2009·Rheumatology International·L Goh, A Samanta
Aug 20, 2009·Clinical Rheumatology·Gleb SlobodinMajed Odeh
May 5, 2004·Best Practice & Research. Clinical Rheumatology·Sandrine GuisFrédéric Lioté
Aug 4, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·Abdellah El Maghraoui
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Cailin Henderson, John C Davis
Jul 27, 2011·Nature Reviews. Rheumatology·Atul A Deodhar
Sep 27, 2013·Rheumatology·Ombretta ViapianaMaurizio Rossini
Jun 24, 2003·Current Opinion in Rheumatology·Juergen BraunJoachim Sieper
Jun 24, 2003·Current Opinion in Rheumatology·Ian R Reid
Jun 18, 2004·Current Opinion in Rheumatology·Yan LiuMillicent A Stone
Jun 16, 2005·Current Opinion in Rheumatology·Jane Zochling, Jürgen Braun
Jun 7, 2007·Current Opinion in Rheumatology·Eric Toussirot, Daniel Wendling
Mar 28, 2012·Current Opinion in Rheumatology·Uta KiltzJuergen Braun
Dec 2, 2008·Clinical calcium·Hiroshi Mitsui
Apr 15, 2004·Annals of the Rheumatic Diseases·N BarkhamP Emery
Aug 30, 2005·Annals of the Rheumatic Diseases·J ZochlingUNKNOWN European League Against Rheumatism
Apr 14, 2006·Annals of the Rheumatic Diseases·R GroverA Kumar
Sep 16, 2006·BMJ : British Medical Journal·Claire M McVeigh, Andrew P Cairns
Feb 16, 2005·Digestion·Pascal JuilleratPierre Michetti
Feb 2, 2008·Digestion·Pascal JuilleratPierre Michetti
Oct 15, 2011·Arthritis Research & Therapy·Piet Geusens, Willem F Lems
Jun 1, 2007·Biologics : Targets & Therapy·Rebecca Grainger, Andrew A Harrison
Jan 1, 2008·Core Evidence·Stephanie HenniganArthur Kavanaugh
Sep 23, 2008·AJR. American Journal of Roentgenology·George Koulouris
Feb 23, 2008·Neurosurgical Focus·Alexander A KhalessiMichael Y Wang
May 7, 2005·Indian Journal of Medical Sciences·S M Akerkar, L S Bichile
May 15, 2003·Current Treatment Options in Gastroenterology·Adrian A. Van Bodegraven, A. Salvador Peña
Feb 14, 2014·Annals of the Rheumatic Diseases·G P R ClunieJ S H Gaston
Dec 27, 2013·Rheumatology·Jacqueline E Paramarta, Dominique Baeten
Dec 10, 2014·Best Practice & Research. Clinical Rheumatology·Enrique Roberto SorianoLiron Caplan
Jan 10, 2004·Current Rheumatology Reports·Stanley B Cohen
Oct 5, 2007·Current Rheumatology Reports·Sean P LaSalle, Atul A Deodhar
Sep 27, 2008·Current Rheumatology Reports·Walter P Maksymowych
Aug 21, 2009·Current Rheumatology Reports·Peter Nash
Aug 4, 2010·Current Rheumatology Reports·Marina Magrey, Muhammad Asim Khan
Dec 8, 2004·Postgraduate Medicine·Allen P Anandarajah, Christopher T Ritchlin
Dec 24, 2005·Expert Opinion on Investigational Drugs·Carlo PalazziIgnazio Olivieri
Sep 23, 2006·Expert Opinion on Investigational Drugs·Ignazio OlivieriCarlo Palazzi
Mar 25, 2014·Expert Opinion on Investigational Drugs·Juergen BraunUta Kiltz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.